Office of the Director, National Institutes of Health; Notice of Meeting, 12797 [2020-04441]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 43 / Wednesday, March 4, 2020 / Notices
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, Room 610, 35 Convent
Drive, Bethesda, MD 20892.
Closed: March 31, 2020, 9:00 a.m. to 3:25
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, Room 610, 35 Convent
Drive, Bethesda, MD 20892.
Contact Person: Andrew J. Griffith, Ph.D.,
MD, Director, Division of Intramural
Research, National Institute on Deafness and
Other Communication Disorders, 35A
Convent Drive, GF 103, Rockville, MD 20892,
(301) 496–1960, griffita@nidcd.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/advisorycommittees, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: February 27, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Board of Scientific
Counselors, National Institutes of Health.
Date: May 15, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: The meeting will include a
discussion of policies and procedures that
apply to the regular review of NIH intramural
scientists and their work.
Place: National Institutes of Health, 1
Center Drive, Building 1, Room 151,
Bethesda, MD 20892.
Conference Line Access: 1–888–233–9215.
Participant Passcode: 59105.
Contact Person: Margaret McBurney,
Program Specialist, Office of the Deputy
Director for Intramural Research, National
Institutes of Health, 1 Center Drive, Room
160, Bethesda, MD 20892–0140, (301) 496–
1921, mmburney@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the Office
of Intramural Research home page: https://
sourcebook.od.nih.gov/.
Dated: February 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–04441 Filed 3–3–20; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2020–04380 Filed 3–3–20; 8:45 am]
BILLING CODE 4140–01–P
jbell on DSKJLSW7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting. The meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors Chairs Meeting, Office of
The Director, National Institutes of
Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
VerDate Sep<11>2014
16:41 Mar 03, 2020
Jkt 250001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
12797
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trial in People Living with HIV.
Date: March 27, 2020.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Suite
209A, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6705 Rockledge Drive, Suite
209A, Bethesda, MD 20892–7924, 301–827–
7912, copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 27, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–04375 Filed 3–3–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Advancing Sustained/
Extended Release for HIV Prevention (A–
SER) (R01 Clinical Trial Not Allowed).
Date: March 30, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 85, Number 43 (Wednesday, March 4, 2020)]
[Notices]
[Page 12797]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04441]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors Chairs Meeting, Office of The Director, National Institutes
of Health.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Board of Scientific Counselors, National
Institutes of Health.
Date: May 15, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: The meeting will include a discussion of policies and
procedures that apply to the regular review of NIH intramural
scientists and their work.
Place: National Institutes of Health, 1 Center Drive, Building
1, Room 151, Bethesda, MD 20892.
Conference Line Access: 1-888-233-9215.
Participant Passcode: 59105.
Contact Person: Margaret McBurney, Program Specialist, Office of
the Deputy Director for Intramural Research, National Institutes of
Health, 1 Center Drive, Room 160, Bethesda, MD 20892-0140, (301)
496-1921, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Office of Intramural
Research home page: https://sourcebook.od.nih.gov/.
Dated: February 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-04441 Filed 3-3-20; 8:45 am]
BILLING CODE 4140-01-P
